Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis

AIMS: Metabolic associated fatty liver disease (MAFLD) is the most common cause of chronic liver disease and is a major health and economic burden in society. New drugs are urgently needed to treat MAFLD. This systematic review and meta-analysis was conducted to evaluate the efficacy of glucagon-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Yuzhao, He, He, Li, Sheyu, Yang, Lidan, Wang, Xia, Liu, Zhi, An, Zhenmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924308/
https://www.ncbi.nlm.nih.gov/pubmed/33664710
http://dx.doi.org/10.3389/fendo.2020.622589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924308/
https://www.ncbi.nlm.nih.gov/pubmed/33664710
http://dx.doi.org/10.3389/fendo.2020.622589

Ejemplares similares